Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J, others dropping infant acetaminophen, as FDA updates OTC liquid med guidelines

This article was originally published in Scrip

Executive Summary

In an action aimed at reducing dosing confusion and errors with over-the-counter (OTC) liquid pediatric acetaminophen, drug makers, including Johnson & Johnson and Perrigo, agreed this week to stop making and selling concentrated infant drops of the pain reliever and fever reducer medicine. Meanwhile, the US FDA issued new guidelines about OTC liquid pain relievers, cold medicine, cough syrups and digestion aids packaged with cups, droppers, syringes or spoons intended to ensure correct measuring.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC012823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel